喘患者对SARS-CoV-2疫苗的抗体反应
Xiaoqin Zhang1, Yifei Tao2, Zhu Song1,3
1Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
概括
喘患者对COVID-19疫苗接种表现出强大的抗体反应,与健康个体相比. 这一发现支持使用喘患者的标准疫苗接种方案,而不需要专门的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和喘研究研究
- 疫苗学 疫苗学 疫苗学
背景情况:
- 病毒感染是常见的喘恶化触发因素.
- 喘具有高IgE的Th2主导免疫环境.
- 这种环境对疫苗反应的影响尚不清楚.
研究的目的:
- 在疫苗接种后的喘患者中调查SARS-CoV-2 S蛋白特定IgG抗体标位.
- 为了比较喘患者和健康对照人群之间的抗体反应.
- 分析不同喘亚组的抗体反应.
主要方法:
- 特定于SARS-CoV-2 S蛋白的血清IgG水平使用ELISA量化.
- 在接种疫苗和未接种疫苗的个体之间比较了抗体标位.
- 分析了喘患者,健康对照组和喘小组之间的差异.
主要成果:
- 接种疫苗的个体显示抗体水平明显高于未接种疫苗的个体.
- 在三个剂量疫苗后,喘患者和健康对照人群之间没有观察到抗体标位的显著差异.
- 不同喘亚组的抗体标位在不同喘亚组之间没有明显差异.
结论:
- 喘患者对COVID-19疫苗产生有效的抗体反应.
- 标准的疫苗接种方案适用于喘患者.
- 根据喘患者的免疫特征,不需要专门的疫苗接种策略.
相关概念视频
Asthma: Pathogenesis and Management
341
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
341
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Cross-reactivity
30.9K
Overview
30.9K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
231
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
231
Antiasthma Drugs: β2-Adrenoceptor Agonists
231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231


